Commonwealth Biotechnologies, Inc. (NASDAQ: CBTE) is pleased to announce additional new bio-defense related contract work. The new contracts total nearly $1.2 million and are with government and private sector clients.
Commonwealth Biotechnologies, Inc. (NASDAQ: CBTE) is pleased to announce additional new bio-defense related contract work. The new contracts total nearly $1.2 million and are with government and private sector clients.
